TUDOR INVESTMENT CORP ET AL

Position in PCVX — Vaxcyte, Inc.

CIK 923093 STAMFORD, CT

Back to PCVX Full portfolio

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

+$0 QoQ

Shares Held

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

6 quarters on record

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Derivatives in PCVX

reported options exposure · as of Jun 30, 2026

CallValue

$1,865,973

CallShares

32,100

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	943,287	$66,643,226
2	RPRX	Royalty Pharma plc	610,736	$34,243,967
3	XENE	Xenon Pharmaceuticals Inc.	545,387	$32,919,559
4	ABVX	Abivax S.A.	187,335	$24,964,262
5	INSM	INSMED Inc	195,391	$20,832,588
6	MLYS	Mineralys Therapeutics, Inc.	738,370	$19,921,222
7	ABCL	AbCellera Biologics Inc.	2,063,191	$16,196,049
8	QURE	uniQure N.V.	328,889	$15,148,627

All Filings in PCVX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,865,973	32,100	+60.5%	Call	Defined	2026-08-14
2026-03-31	$1,162,200	20,000	+90.5%	Call	Defined	2026-05-15
2025-09-30	$2,630,720	73,035	+37.6%	Shares	Defined	2025-12-09
2025-09-30	$378,210	10,500	-4.5%	Call	Defined	2025-12-09
2025-06-30	$357,610	11,000	—	Call	Defined	2025-08-14
2025-06-30	$1,725,695	53,082	+70.9%	Shares	Defined	2025-08-14
2023-06-30	$1,551,535	31,068	-17.9%	Shares	Defined	2023-08-14
2023-03-31	$1,419,030	37,861	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.